Gert Van den Eynden, Ph.D. - Publications

Affiliations: 
2008 Universiteit Antwerpen (Belgium) 
Area:
Pathology, Oncology

33 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 De Laere B, Oeyen S, Van Oyen P, Ghysel C, Ampe J, Ost P, Demey W, Hoekx L, Schrijvers D, Brouwers B, Lybaert W, Everaert E, Van Kerckhove P, De Maeseneer D, Strijbos M, ... ... Van den Eynden G, et al. Circulating tumor cells and survival in abiraterone- and enzalutamide-treated patients with castration-resistant prostate cancer. The Prostate. PMID 29431193 DOI: 10.1002/pros.23488  0.64
2016 Pastushenko I, Van den Eynden GG, Vicente-Arregui S, Prieto-Torres L, Alvarez-Alegret R, Querol I, Dirix LY, Carapeto FJ, Vermeulen PB, Van Laere SJ. Increased Angiogenesis and Lymphangiogenesis in Metastatic Sentinel Lymph Nodes Is Associated With Nonsentinel Lymph Node Involvement and Distant Metastasis in Patients With Melanoma. The American Journal of Dermatopathology. PMID 26909582 DOI: 10.1097/DAD.0000000000000488  0.68
2015 Eefsen RL, Engelholm L, Alpizar-Alpizar W, Van den Eynden GG, Vermeulen PB, Christensen IJ, Laerum OD, Rolff HC, Høyer-Hansen G, Vainer B, Osterlind K, Illemann M. Inflammation and uPAR-Expression in Colorectal Liver Metastases in Relation to Growth Pattern and Neo-adjuvant Therapy. Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society. 8: 93-100. PMID 26268716 DOI: 10.1007/s12307-015-0172-z  0.68
2015 Pastushenko I, Vermeulen PB, Vicente-Arregui S, Van den Eynden GG, Alvarez-Alegret R, Querol I, Rutten A, Carapeto FJ, Dirix LY, Van Laere S. Peritumoral D2-40 Chalkley score independently predicts metastases and survival in patients with cutaneous malignant melanoma. Journal of Cutaneous Pathology. 42: 699-711. PMID 26264662 DOI: 10.1111/cup.12571  0.68
2015 Sonnenblick A, Brohée S, Fumagalli D, Vincent D, Venet D, Ignatiadis M, Salgado R, Van den Eynden G, Rothé F, Desmedt C, Neven P, Loibl S, Denkert C, Joensuu H, Loi S, et al. Constitutive phosphorylated STAT3-associated gene signature is predictive for trastuzumab resistance in primary HER2-positive breast cancer. Bmc Medicine. 13: 177. PMID 26234940 DOI: 10.1186/s12916-015-0416-2  0.52
2015 Eefsen RL, Vermeulen PB, Christensen IJ, Laerum OD, Mogensen MB, Rolff HC, Van den Eynden GG, Høyer-Hansen G, Osterlind K, Vainer B, Illemann M. Growth pattern of colorectal liver metastasis as a marker of recurrence risk. Clinical & Experimental Metastasis. 32: 369-81. PMID 25822899 DOI: 10.1007/s10585-015-9715-4  0.68
2015 Pastushenko I, Vicente-Arregui S, Van den Eynden GG, Gracia-Cazaña T, Carapeto FJ, Alvarez-Alegret R, Dirix LY, Vermeulen PB, Van Laere S. Melanomas arising on skin with chronic sun-induced damage exhibit low degree of angiogenesis and lymphangiogenesis. The American Journal of Dermatopathology. 37: 451-4. PMID 25747811 DOI: 10.1097/DAD.0000000000000265  0.68
2014 Pastushenko I, Gracia-Cazaña T, Vicente-Arregui S, Van den Eynden GG, Ara M, Vermeulen PB, Carapeto FJ, Van Laere SJ. Squamous cell carcinomas of the skin explore angiogenesis-independent mechanisms of tumour vascularization. Journal of Skin Cancer. 2014: 651501. PMID 24891955 DOI: 10.1155/2014/651501  0.68
2014 Pastushenko I, Vermeulen PB, Van den Eynden GG, Rutten A, Carapeto FJ, Dirix LY, Van Laere S. Mechanisms of tumour vascularization in cutaneous malignant melanoma: clinical implications. The British Journal of Dermatology. 171: 220-33. PMID 24641095 DOI: 10.1111/bjd.12973  0.68
2014 Marsan M, Van den Eynden G, Limame R, Neven P, Hauspy J, Van Dam PA, Vergote I, Dirix LY, Vermeulen PB, Van Laere SJ. A core invasiveness gene signature reflects epithelial-to-mesenchymal transition but not metastatic potential in breast cancer cell lines and tissue samples. Plos One. 9: e89262. PMID 24586640 DOI: 10.1371/journal.pone.0089262  0.68
2014 Van den Eynden GG, van Dam PJ, Stroobants S, Dirix L, Vermeulen P. Histopathological evaluation of resected colorectal cancer liver metastases: what should be done? Histopathology. 64: 315-6. PMID 24330151 DOI: 10.1111/his.12259  0.64
2014 Pastushenko I, Vermeulen PB, Carapeto FJ, Van den Eynden G, Rutten A, Ara M, Dirix LY, Van Laere S. Blood microvessel density, lymphatic microvessel density and lymphatic invasion in predicting melanoma metastases: systematic review and meta-analysis. The British Journal of Dermatology. 170: 66-77. PMID 24134623 DOI: 10.1111/bjd.12688  0.68
2012 Eefsen RL, Van den Eynden GG, Høyer-Hansen G, Brodt P, Laerum OD, Vermeulen PB, Christensen IJ, Wettergren A, Federspiel B, Willemoe GL, Vainer B, Osterlind K, Illemann M. Histopathological growth pattern, proteolysis and angiogenesis in chemonaive patients resected for multiple colorectal liver metastases. Journal of Oncology. 2012: 907971. PMID 22919385 DOI: 10.1155/2012/907971  0.68
2011 Trinh XB, van Dam PA, Vermeulen PB, Van Laere SJ, Van den Eynden GG, Tjalma WA, Dirix LY. VEGF-A-independent and angiogenesis-dependent tumour growth in patients with metastatic breast cancer. Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 13: 805-8. PMID 22082645 DOI: 10.1007/s12094-011-0737-3  0.68
2009 Baldewijns MM, van Vlodrop IJ, Smits KM, Vermeulen PB, Van den Eynden GG, Schot F, Roskams T, van Poppel H, van Engeland M, de Bruïne AP. Different angiogenic potential in low and high grade sporadic clear cell renal cell carcinoma is not related to alterations in the von Hippel-Lindau gene. Cellular Oncology : the Official Journal of the International Society For Cellular Oncology. 31: 371-82. PMID 19759417 DOI: 10.3233/CLO-2009-0482  0.68
2009 Van den Eynden GG, Van Laere SJ, Van der Auwera I, Trinh XB, Van Marck EA, Dirix LY, Vermeulen PB. Two distinct expression patterns of urokinase, urokinase receptor and plasminogen activator inhibitor-1 in colon cancer liver metastases. International Journal of Cancer. 125: 1494-6. PMID 19536843 DOI: 10.1002/ijc.24524  0.68
2009 Trinh XB, Tjalma WA, Vermeulen PB, Van den Eynden G, Van der Auwera I, Van Laere SJ, Helleman J, Berns EM, Dirix LY, van Dam PA. The VEGF pathway and the AKT/mTOR/p70S6K1 signalling pathway in human epithelial ovarian cancer. British Journal of Cancer. 100: 971-8. PMID 19240722 DOI: 10.1038/sj.bjc.6604921  0.68
2009 Baldewijns MM, Roskams T, Ballet V, Van den Eynden GG, Van Laere SJ, Van der Auwera I, Lerut E, De Bruïne AP, Thijssen VL, Vermeulen PB, van Poppel H. A low frequency of lymph node metastasis in clear-cell renal cell carcinoma is related to low lymphangiogenic activity. Bju International. 103: 1626-31. PMID 19154467 DOI: 10.1111/j.1464-410X.2008.08272.x  0.68
2008 Van der Auwera I, Van Laere SJ, Van den Bosch SM, Van den Eynden GG, Trinh BX, van Dam PA, Colpaert CG, van Engeland M, Van Marck EA, Vermeulen PB, Dirix LY. Aberrant methylation of the Adenomatous Polyposis Coli (APC) gene promoter is associated with the inflammatory breast cancer phenotype. British Journal of Cancer. 99: 1735-42. PMID 18841156 DOI: 10.1038/sj.bjc.6604705  0.68
2008 Van den Eynden GG, Smid M, Van Laere SJ, Colpaert CG, Van der Auwera I, Bich TX, van Dam P, den Bakker MA, Dirix LY, Van Marck EA, Vermeulen PB, Foekens JA. Gene expression profiles associated with the presence of a fibrotic focus and the growth pattern in lymph node-negative breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 2944-52. PMID 18483361 DOI: 10.1158/1078-0432.CCR-07-4397  0.68
2007 Van den Eynden GG, Vandenberghe MK, van Dam PJ, Colpaert CG, van Dam P, Dirix LY, Vermeulen PB, Van Marck EA. Increased sentinel lymph node lymphangiogenesis is associated with nonsentinel axillary lymph node involvement in breast cancer patients with a positive sentinel node. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 5391-7. PMID 17875768 DOI: 10.1158/1078-0432.CCR-07-1230  0.68
2007 Van den Eynden GG, Van der Auwera I, Colpaert CG, Dirix LY, Van Marck EA, Vermeulen PB. Letter to the editor: Lymphangiogenesis in primary breast cancer. Cancer Letters. 256: 279-81; author reply. PMID 17714860 DOI: 10.1016/j.canlet.2007.07.005  0.68
2007 Van Laere SJ, Van der Auwera I, Van den Eynden GG, van Dam P, Van Marck EA, Vermeulen PB, Dirix LY. NF-kappaB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/or ErbB2 overexpression and MAPK hyperactivation. British Journal of Cancer. 97: 659-69. PMID 17700572 DOI: 10.1038/sj.bjc.6603906  0.68
2007 Van den Eynden GG, Van der Auwera I, Van Laere SJ, Trinh XB, Colpaert CG, van Dam P, Dirix LY, Vermeulen PB, Van Marck EA. Comparison of molecular determinants of angiogenesis and lymphangiogenesis in lymph node metastases and in primary tumours of patients with breast cancer. The Journal of Pathology. 213: 56-64. PMID 17674348 DOI: 10.1002/path.2211  0.68
2007 Van den Eynden GG, Colpaert CG, Couvelard A, Pezzella F, Dirix LY, Vermeulen PB, Van Marck EA, Hasebe T. A fibrotic focus is a prognostic factor and a surrogate marker for hypoxia and (lymph)angiogenesis in breast cancer: review of the literature and proposal on the criteria of evaluation. Histopathology. 51: 440-51. PMID 17593207 DOI: 10.1111/j.1365-2559.2007.02761.x  0.68
2007 Van den Eynden GG, Van Laere SJ, Van der Auwera I, Gilles L, Burn JL, Colpaert C, van Dam P, Van Marck EA, Dirix LY, Vermeulen PB. Differential expression of hypoxia and (lymph)angiogenesis-related genes at different metastatic sites in breast cancer. Clinical & Experimental Metastasis. 24: 13-23. PMID 17295094 DOI: 10.1007/s10585-006-9049-3  0.6
2007 Van den Eynden GG, Neyret A, Fumey G, Rizk-Rabin M, Vermeulen PB, Bouizar Z, Body JJ, Dirix LY. PTHrP, calcitonin and calcitriol in a case of severe, protracted and refractory hypercalcemia due to a pancreatic neuroendocrine tumor. Bone. 40: 1166-71. PMID 17188588 DOI: 10.1016/j.bone.2006.11.009  0.68
2006 Van Laere SJ, Van der Auwera I, Van den Eynden GG, Elst HJ, Weyler J, Harris AL, van Dam P, Van Marck EA, Vermeulen PB, Dirix LY. Nuclear factor-kappaB signature of inflammatory breast cancer by cDNA microarray validated by quantitative real-time reverse transcription-PCR, immunohistochemistry, and nuclear factor-kappaB DNA-binding. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 3249-56. PMID 16740744 DOI: 10.1158/1078-0432.CCR-05-2800  0.6
2006 Van Laere SJ, Van den Eynden GG, Van der Auwera I, Vandenberghe M, van Dam P, Van Marck EA, van Golen KL, Vermeulen PB, Dirix LY. Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling. Breast Cancer Research and Treatment. 95: 243-55. PMID 16261404 DOI: 10.1007/s10549-005-9015-9  0.68
2006 Van den Eynden GG, Van Laere SJ, Van der Auwera I, Merajver SD, Van Marck EA, van Dam P, Vermeulen PB, Dirix LY, van Golen KL. Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer. Breast Cancer Research and Treatment. 95: 219-28. PMID 16244790 DOI: 10.1007/s10549-005-9002-1  0.6
2005 Van der Auwera I, Van den Eynden GG, Colpaert CG, Van Laere SJ, van Dam P, Van Marck EA, Dirix LY, Vermeulen PB. Tumor lymphangiogenesis in inflammatory breast carcinoma: a histomorphometric study. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 7637-42. PMID 16278382 DOI: 10.1158/1078-0432.CCR-05-1142  0.68
2005 Van Laere S, Van der Auwera I, Van den Eynden GG, Fox SB, Bianchi F, Harris AL, van Dam P, Van Marck EA, Vermeulen PB, Dirix LY. Distinct molecular signature of inflammatory breast cancer by cDNA microarray analysis. Breast Cancer Research and Treatment. 93: 237-46. PMID 16172796 DOI: 10.1007/s10549-005-5157-z  0.68
2004 Van der Auwera I, Van Laere SJ, Van den Eynden GG, Benoy I, van Dam P, Colpaert CG, Fox SB, Turley H, Harris AL, Van Marck EA, Vermeulen PB, Dirix LY. Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 7965-71. PMID 15585631 DOI: 10.1158/1078-0432.CCR-04-0063  0.68
Show low-probability matches.